Fundz

Mosaic Therapeutics Appoints Dr Stephen Shuttleworth as Chief Scientific Officer

PRIVATENov 17, 2025

Position

Chief Scientific Officer

Company

Mosaic Therapeutics

Stephen Shuttleworth
stephen@mosaic-tx.com
BabrahamBiotechnologyHealth CareTherapeutics

Description

Mosaic Therapeutics announced the appointment of Dr Stephen Shuttleworth as Chief Scientific Officer. He brings over 30 years of experience in pharmaceutical science and biotech leadership.

Who to call at Mosaic Therapeutics, and when

A new leader at Mosaic Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Mosaic Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mosaic Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mosaic Therapeutics

Location

Babraham, Cambridgeshire, United Kingdom

About

Mosaic Therapeutics is an oncology therapeutics company that is building a category leader in Synergistic Precision Oncology. The company applies advanced experimental and computational platforms to identify oncology combinations for biomarker-defined patient populations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mosaic Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Stephen
Likely contact at this company
••••••••@••••••••

See Stephen's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Mosaic Therapeutics's next move

Learn about Strategic plan

Mosaic Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.